Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
532.80
-5.03 (-0.94%)
Feb 21, 2025, 3:15 PM EST - Market open
Thermo Fisher Revenue
In the year 2024, Thermo Fisher had annual revenue of $42.88B with 0.05% growth. Thermo Fisher had revenue of $11.40B in the quarter ending December 31, 2024, with 4.68% growth.
Revenue (ttm)
$42.88B
Revenue Growth
+0.05%
P/S Ratio
4.79
Revenue / Employee
$343,032
Employees
125,000
Market Cap
203.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 42.88B | 22.00M | 0.05% |
| Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
| Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
| Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
| Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Abbott Laboratories | 41.95B |
TMO News
- 1 day ago - Thermo Fisher Scientific Increases Quarterly Dividend - Business Wire
- 1 day ago - Thermo Fisher Scientific Elects New Director to Board - Business Wire
- 9 days ago - Thermo Fisher Scientific's New Spatial Imaging System Enables Researchers to Generate High-quality Data, Making it Easier to Enter the Field of Spatial Tissue Proteomics - Business Wire
- 9 days ago - Laboratory Supplies Market Analysis 2022-2024 and Forecast 2025-2030, Featuring Profiles of Key Players - Th. Geyer, Thermo Fisher, Spectrum Chemical Manufacturing Corp., Ing. - GlobeNewsWire
- 16 days ago - Thermo Fisher Scientific Launches International CorEvitas Clinical Registry in Adolescent Alopecia Areata - Business Wire
- 17 days ago - Thermo Fisher Scientific Accelerates 100 Percent Renewable Electricity Goal for European Operations with New Solar Power Agreement with X-ELIO - Business Wire
- 21 days ago - Thermo Fisher Scientific: Finally Ready For A Breakout? (Upgrade) - Seeking Alpha
- 22 days ago - Thermo Fisher Stock Surges as Medical Device Maker's Results Top Estimates - Investopedia